Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Howden

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Gut|September 1, 1987
Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugsD B Jones, C W Howden, D W Burget, et al.
European Journal of Clinical Pharmacology|January 1, 1987
The effects of omeprazole on endocrine function in manA J MacGilchrist, C W Howden, C J Kenyon, et al.
Alimentary Pharmacology & Therapeutics|April 1, 2006
Dose-response evaluation of the antisecretory effect of continuous infusion intravenous lansoprazole regimens over 48 hC W Howden, D C Metz, B Hunt, et al.
Archives of Internal Medicine|July 24, 1995
The rationale for continuous maintenance treatment of reflux esophagitisC W Howden, D O Castell, S Cohen, et al.
Alimentary Pharmacology & Therapeutics|February 13, 2009
Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed-release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitisD C Metz, C W Howden, M C Perez, et al.
The American Journal of Gastroenterology|August 19, 2000
Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillanceV K Sharma, F A Corder, J P Raufman, et al.
Alimentary Pharmacology & Therapeutics|February 17, 2006
Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national surveyW D Chey, S Eswaren, C W Howden, et al.
Alimentary Pharmacology & Therapeutics|August 1, 1987
Marked suppression of stimulated gastric acid and pepsin secretion by enisoprost, a new PGE1 analogueC W Howden, D W Burget, C Silletti, et al.
Alimentary Pharmacology & Therapeutics|November 6, 2004
Review article: oesophageal complications and consequences of persistent gastro-oesophageal reflux diseaseJ Pisegna, G Holtmann, C W Howden, et al.
Gut|December 1, 1991
Increased intestinal permeability in ankylosing spondylitis--primary lesion or drug effect?A J Morris, C W Howden, C Robertson, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Gut|September 1, 1987
Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugsD B Jones, C W Howden, D W Burget, et al.
European Journal of Clinical Pharmacology|January 1, 1987
The effects of omeprazole on endocrine function in manA J MacGilchrist, C W Howden, C J Kenyon, et al.
Alimentary Pharmacology & Therapeutics|April 1, 2006
Dose-response evaluation of the antisecretory effect of continuous infusion intravenous lansoprazole regimens over 48 hC W Howden, D C Metz, B Hunt, et al.
Archives of Internal Medicine|July 24, 1995
The rationale for continuous maintenance treatment of reflux esophagitisC W Howden, D O Castell, S Cohen, et al.
Alimentary Pharmacology & Therapeutics|February 13, 2009
Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed-release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitisD C Metz, C W Howden, M C Perez, et al.
The American Journal of Gastroenterology|August 19, 2000
Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillanceV K Sharma, F A Corder, J P Raufman, et al.
Alimentary Pharmacology & Therapeutics|February 17, 2006
Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national surveyW D Chey, S Eswaren, C W Howden, et al.
Alimentary Pharmacology & Therapeutics|August 1, 1987
Marked suppression of stimulated gastric acid and pepsin secretion by enisoprost, a new PGE1 analogueC W Howden, D W Burget, C Silletti, et al.
Alimentary Pharmacology & Therapeutics|November 6, 2004
Review article: oesophageal complications and consequences of persistent gastro-oesophageal reflux diseaseJ Pisegna, G Holtmann, C W Howden, et al.
Gut|December 1, 1991
Increased intestinal permeability in ankylosing spondylitis--primary lesion or drug effect?A J Morris, C W Howden, C Robertson, et al.
Pageof 15